VEGFR2 / Streptavidin / IMC-1121B (Ramucirumab)
VEGFR2 / Streptavidin / IMC-1121B (Ramucirumab)
Product Details
| Supplier | Absolute Antibody | |
|---|---|---|
| Catalog #: | Ab03058-10.29-streptavidin (View supplier product page) | |
| Size | 100 μg | |
| Price | ||
| Antigen | VEGFR2 | |
| Clone | IMC-1121B (Ramucirumab) | |
| Host | Human | |
| Isotype | Fab Fragment | |
| Conjugate | Streptavidin | |
| Target Species | Human | |
| Applications | FC, IHC, X-Ray Crystallography, In Vitro, In Vivo | |
| Description | Anti-VEGFR2 [IMC-1121B (Ramucirumab)] |
About VEGFR2 and Streptavidin
| VEGFR2 | Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009] |
|---|
Citations
| Additional Sources |
|
|---|
